The gene DYRK1A could be a potential therapeutic target to treat ‘glue ear’ in people with Down syndrome, according to a new study.

The genetic cause for the most common type of hearing loss in children with Down syndrome has been identified in mice by ...

This study addresses fundamental questions surrounding otitis media effusion in Down syndrome, identifying DYRK1A as a key gene involved in the condition. The findings are compelling, highlighting ...

Its share price is currently down roughly 30% from its high. On the heels of the big sell-offs, Uber is now valued at roughly 21 times this year's expected earnings -- a level that looks ...

Antenatal diagnosis of Trisomy 13 is often made by karyotyping. This is typically performed after an assessment of risk for a chromosomal disorder is made by the maternal healthcare provider.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

now 21, has continued growing her modeling career, representing young women who have Down syndrome. She’s filmed a Kohl's online back-to-school campaign. A CVS in-store, social media and in ...

The ICOD (Improving Condition in Down syndrome) project, a pioneering study in addressing the cognitive difficulties associated with Down syndrome, has demonstrated the safety of treatment with ...

educators and caregivers who may not understand Down syndrome, a genetic disorder caused when abnormal cell division results in extra genetic material from chromosome 21. Down syndrome can cause a ...

Leah Meyer was born with Down syndrome, but she’s never let that limit her capabilities. “It was the normal routine of any parent,” said Drew Meyer, her dad. “It was a shock when we found ...

Sie Whitten is president and CEO of the GLOBAL Down Syndrome Foundation. Foxx is an Academy Award and Grammy Award winner and a GLOBAL international spokesperson. On Dec. 4, the largest-ever ...